Charles Divita III - 10 Jun 2026 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Reporting relationship: CHIEF EXECUTIVE OFFICER, Director
Issuer ticker: TDOC
Reported as of: 10 Jun 2026
Net transaction value: -$125,470
SEC form: 4
Accepted by SEC: 12 Jun 2026, 16:05:24 UTC
Prior SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Adam C. Vandervoort, Attorney-in-Fact

Key filing fact

Charles Divita III filed Form 4 for Teladoc Health, Inc. (TDOC) on 12 Jun 2026.

Key facts

This page summarizes Charles Divita III's Form 4 filing for Teladoc Health, Inc. (TDOC).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 12 Jun 2026, 16:05.

Change

Previous filing in this sequence was filed on 03 Jun 2026.
Current net transaction value: -$125,470.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001347535 Primary reporting owner

DIVITA CHARLES III

Relationship: CHIEF EXECUTIVE OFFICER, Director
Address: C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, SUITE 1700, NEW YORK
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Signature date: 12 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,642
Change %: +0.93%
Price
Shares after: 393,536
Date: 10 Jun 2026
Ownership: Direct
Footnotes: F1

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +39,160
Change %: +10%
Price
Shares after: 432,696
Date: 10 Jun 2026
Ownership: Direct
Footnotes: F2

TDOC transaction

Common Stock

Sale

Transaction value: $125,470
Shares: -18,074
Change %: -4.2%
Price: $6.94
Shares after: 414,622
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TDOC transaction Derivative

Performance Stock Units

Options Exercise

Transaction value
Shares: -3,642
Change %: -20%
Price: $0.000000^*
Shares after: 14,568
Date: 10 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,642
Exercise price
Footnotes: F1, F4

TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -39,160
Change %: -20%
Price: $0.000000^*
Shares after: 156,643
Date: 10 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 39,160
Exercise price
Footnotes: F2, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Footnote F2

Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Footnote F3

Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Footnote F4

On June 10, 2026, the reporting person earned 23,591 performance stock units, vesting as to seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months.

Footnote F5

On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.